tiprankstipranks
AngioDynamics upgraded to Outperform from Perform at Oppenheimer
The Fly

AngioDynamics upgraded to Outperform from Perform at Oppenheimer

Oppenheimer analyst Steven Lichtman upgraded AngioDynamics to Outperform from Perform with a $12 price target.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles